Doctors want specifics on biosimilar labels
A survey of 400 biologics-prescribing physicians found they want labels that clearly indicate if a drug is a biosimilar. This was just one data point they said would shore up their confidence in biosimilars.
The survey was conducted by the industry- and professional-supported Alliance for Safe Biologic Medicines. The ASBM said the survey also showed that the longer a doctor had been practicing, the more likely he or she were to want this information on a biosimilar's label.
Among the physicians' label requests:
State indications for which the branded biologic is approved and the ones for which the biosimilar is not
Share data that shows the similarity between the biosimilar and the branded biologic